2017
DOI: 10.1016/j.jval.2017.08.2260
|View full text |Cite
|
Sign up to set email alerts
|

Impact of Comorbidities on The Risk And Cost of Hospitalization In Hiv-Infected Patients: Real World Data From The Abruzzo Region

Abstract: To study the efficacy and safety of a specific first line antiretroviral (ART) regimen composed of tenofovir (TDF), lamivudine (3TC) and efavirenz (EFV), which was used until recently as the preferred first line treatment for adults in Brazil and is still amongst the recommended by the World Health Organization. Methods: In April, 2017, we conducted a systematic search of the literature in MEDLINE via Pubmed, Cochrane CENTRAL, EMBASE and Lilacs for cohorts that reported on toxicity or CD4 lymphocyte count or v… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles